BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. ("NPS") (NASDAQ: NPSP) today announced the pricing of an underwritten public offering of 11,000,000 shares of its common stock at a price to the public of $9.00 per share. The offering was increased from the previously announced amount of 9,000,000 shares. NPS expects to receive net proceeds, after deducting underwriting discounts and commissions and other offering expenses, of approximately $93 million. In addition, NPS has granted the underwriters a 30-day option to purchase up to an aggregate of 1,650,000 additional shares of common stock. The offering is expected to close on or about April 19, 2011, subject to customary closing conditions. Citi and Leerink Swann LLC are acting as joint book-running managers. Canaccord Genuity Inc. and Needham & Company, LLC are senior co-managers and Brean Murray, Carret & Co., Summer Street Research Partners and ThinkEquity LLC are co-managers for the offering.
